Lenomorelin

Generic Name
Lenomorelin
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
258279-04-8
Unique Ingredient Identifier
UXG268Q86R
Background

Lenomorelin has been investigated for the treatment and basic science of Cancer, Alcoholism, Metabolism, Hypopituitarism, and Frailty Syndrome, among others.

Associated Conditions
-
Associated Therapies
-

Ghrelin for Alcohol Use in Non-Treatment-Seeking Heavy Drinkers

First Posted Date
2013-01-29
Last Posted Date
2018-08-03
Lead Sponsor
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Target Recruit Count
17
Registration Number
NCT01779024
Locations
🇺🇸

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States

RYGB and the Gastric Adipose Axis

First Posted Date
2011-11-18
Last Posted Date
2018-05-21
Lead Sponsor
Vanderbilt University
Target Recruit Count
49
Registration Number
NCT01474785
Locations
🇺🇸

Vanderbilt University Medical Center, Nashville, Tennessee, United States

The Effect of Pharmacological Antilipolysis on the Metabolic Effects of Ghrelin

First Posted Date
2010-09-27
Last Posted Date
2017-10-30
Lead Sponsor
University of Aarhus
Target Recruit Count
8
Registration Number
NCT01209416
Locations
🇩🇰

University Hospital of Aarhus, Aarhus, Denmark

Effects of Ghrelin on Alcohol Cue Reactivity and Craving

Not Applicable
Completed
Conditions
Interventions
First Posted Date
2010-08-27
Last Posted Date
2014-05-15
Lead Sponsor
Brown University
Target Recruit Count
45
Registration Number
NCT01190085
Locations
🇺🇸

Brown University Center for Alcohol and Addiction Studies, Providence, Rhode Island, United States

Individual Dose-escalated Bi-daily Subcutaneously (sc) Ghrelin in Cancer Cachexia: a Phase I/II Study

Phase 1
Completed
Conditions
Interventions
First Posted Date
2009-07-07
Last Posted Date
2017-08-01
Lead Sponsor
Cantonal Hospital of St. Gallen
Target Recruit Count
21
Registration Number
NCT00933361
Locations
🇨🇭

Cantonal Hospital St. Gallen KSSG, St. Gallen, Switzerland

Effect of Ghrelin on Sympathetic Nervous System

Not Applicable
Completed
Conditions
First Posted Date
2009-06-03
Last Posted Date
2023-09-14
Lead Sponsor
Baker Heart and Diabetes Institute
Target Recruit Count
46
Registration Number
NCT00912587
Locations
🇦🇺

Alfred & Baker Medical Unit, Melbourne, Victoria, Australia

Peripheral Metabolic Effects of Ghrelin

Phase 1
Completed
Conditions
Interventions
First Posted Date
2008-10-15
Last Posted Date
2009-02-03
Lead Sponsor
University of Aarhus
Target Recruit Count
8
Registration Number
NCT00771940
Locations
🇩🇰

Aarhus University Hospital, Aarhus, Denmark

Ghrelin - A Possible Opportunity to Improve Appetite

Phase 3
Completed
Conditions
Interventions
First Posted Date
2008-05-21
Last Posted Date
2009-08-21
Lead Sponsor
Göteborg University
Target Recruit Count
30
Registration Number
NCT00681486
Locations
🇸🇪

Department of surgery, Sahlgrenska University Hospital, Göteborg, Sweden

Effects of Ghrelin on the Sleep-EEG and Nocturnal Secretion of Hormones

Not Applicable
Completed
Conditions
First Posted Date
2007-03-14
Last Posted Date
2007-10-31
Lead Sponsor
Max-Planck-Institute of Psychiatry
Target Recruit Count
80
Registration Number
NCT00447512
Locations
🇩🇪

Max Planck Institute of Psychiatry, Munich, Germany

© Copyright 2024. All Rights Reserved by MedPath